跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salbrosin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salbrosin
Approved
STANDARD
Salbrosin
Unknown
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c4f13d4590ccc631
Company
Unknown
Type
Standard
Approval Details
Approval Id
c4f13d4590ccc631
Drug Approval Philippines Name
Salbrosin
Product Name
Salbrosin
Registration Number
DR-XY45142
Brand Name
Salbrosin
Generic Name
Salbutamol (as sulfate) + Bromhexine hydrochloride + Guaifenesin
Dosage Form
Syrup
Dosage Strength
2 mg/8 mg/50 mg per 5 mL
Issuance Date
29 June 2022
Expiry Date
03 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c4f13d4590ccc631
Type
Standard
Back to Philippines FDA Approvals